Intravenous Acetaminophen versus Morphine Sulfate in Pain Management of Acute Renal Colic; a Randomized Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017080835565N1

Enrollment

355

Registered

2017-08-14

Start date

2015-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal colic. Unspecified renal colic

Interventions

intervention group: 1gr of IV acetaminophen manufactured by Exir Company, Iran in 100 ml of normal saline and duration of infusion is15 minutes control group:0.1mg/kg intravenous (IV) morphine, manu

Treatment - Drugs

intervention group: 1gr of IV acetaminophen manufactured by Exir Company, Iran in 100 ml of normal saline and duration of infusion is15 minutes control group:0.1mg/kg intravenous (IV) morphine, man

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient with renal colic , age between 18 -55 years old Exclusion criteria: allergy to morphine and paracetamol , fever , pregnant , history of addiction , instability of vital signs , liver function disease , renal function disease , renal transplant

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Analgesia after drug infusion. Timepoint: 0,15,30,60,120 after intervention. Method of measurement: visual analog scale device.	—

Secondary

Measure	Time frame
Vertigo,vomiting. Timepoint: 0,15,30,60,120 after intervention. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthossein montazer

Mazandaran University of Medical Sciences

hmontazer66@yahoo.com+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026